Clinical trial
A Multicenter Standard of Care-Controlled Study to Evaluate the Long-Term Safety of Bicifadine for the Treatment of Chronic Low Back Pain
NCT00281645 is registered in ClinicalTrials.gov with DOV Pharmaceutical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Standard of Care-Controlled Study to Evaluate the Long-Term Safety of Bicifadine for the Treatment of Chronic Low Back Pain
- Lead sponsor
- DOV Pharmaceutical, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- Not reported
- Enrollment
- 1,250
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic low back pain